Your browser doesn't support javascript.
loading
Glial cell line-derived neurotrophic factor receptor Rearranged during transfection agonist supports dopamine neurons in Vitro and enhances dopamine release In Vivo.
Mahato, Arun Kumar; Kopra, Jaakko; Renko, Juho-Matti; Visnapuu, Tanel; Korhonen, Ilari; Pulkkinen, Nita; Bespalov, Maxim M; Domanskyi, Andrii; Ronken, Eric; Piepponen, T Petteri; Voutilainen, Merja H; Tuominen, Raimo K; Karelson, Mati; Sidorova, Yulia A; Saarma, Mart.
Afiliação
  • Mahato AK; Laboratory of Molecular Neuroscience, Institute of Biotechnology, Helsinki Institute of Life Science, Viikinkaari 5D, University of Helsinki, Helsinki, Finland.
  • Kopra J; Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, Helsinki, Finland.
  • Renko JM; Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, Helsinki, Finland.
  • Visnapuu T; Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, Helsinki, Finland.
  • Korhonen I; Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, Helsinki, Finland.
  • Pulkkinen N; Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, Helsinki, Finland.
  • Bespalov MM; Laboratory of Molecular Neuroscience, Institute of Biotechnology, Helsinki Institute of Life Science, Viikinkaari 5D, University of Helsinki, Helsinki, Finland.
  • Domanskyi A; Laboratory of Molecular Neuroscience, Institute of Biotechnology, Helsinki Institute of Life Science, Viikinkaari 5D, University of Helsinki, Helsinki, Finland.
  • Ronken E; Solvay Pharmaceuticals, Weesp, Netherlands.
  • Piepponen TP; Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, Helsinki, Finland.
  • Voutilainen MH; Laboratory of Molecular Neuroscience, Institute of Biotechnology, Helsinki Institute of Life Science, Viikinkaari 5D, University of Helsinki, Helsinki, Finland.
  • Tuominen RK; Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, Helsinki, Finland.
  • Karelson M; Institute of Chemistry, Tartu University, Tartu, Estonia.
  • Sidorova YA; Laboratory of Molecular Neuroscience, Institute of Biotechnology, Helsinki Institute of Life Science, Viikinkaari 5D, University of Helsinki, Helsinki, Finland.
  • Saarma M; Laboratory of Molecular Neuroscience, Institute of Biotechnology, Helsinki Institute of Life Science, Viikinkaari 5D, University of Helsinki, Helsinki, Finland.
Mov Disord ; 35(2): 245-255, 2020 02.
Article em En | MEDLINE | ID: mdl-31840869
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Substância Negra / Fator Neurotrófico Derivado de Linhagem de Célula Glial / Neurônios Dopaminérgicos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Substância Negra / Fator Neurotrófico Derivado de Linhagem de Célula Glial / Neurônios Dopaminérgicos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article